[Drug therapy of rheumatoid arthritis: where do biologics and novel synthetic disease-modifying antirheumatic drugs stand today?].

Kaudewitz D, Lorenz HM

Open source

DOI
10.1007/s00108-023-01554-6
Published
2023 Oct
Container
Innere Medizin (Heidelberg, Germany)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00108-023-01554-6,
  title = {[Drug therapy of rheumatoid arthritis: where do biologics and novel synthetic disease-modifying antirheumatic drugs stand today?].},
  author = {Kaudewitz D and Lorenz HM},
  year = {2023},
  journal = {Innere Medizin (Heidelberg, Germany)},
  doi = {10.1007/s00108-023-01554-6},
  url = {https://doi.org/10.1007/s00108-023-01554-6}
}

RIS

TY  - JOUR
TI  - [Drug therapy of rheumatoid arthritis: where do biologics and novel synthetic disease-modifying antirheumatic drugs stand today?].
AU  - Kaudewitz D
AU  - Lorenz HM
PY  - 2023
JO  - Innere Medizin (Heidelberg, Germany)
DO  - 10.1007/s00108-023-01554-6
UR  - https://doi.org/10.1007/s00108-023-01554-6
ER  - 

APA

D, K., & HM, L. (2023). [Drug therapy of rheumatoid arthritis: where do biologics and novel synthetic disease-modifying antirheumatic drugs stand today?].. Innere Medizin (Heidelberg, Germany). https://doi.org/10.1007/s00108-023-01554-6

Source records